Peripheral Arterial Disease Trial, Recruiting NCT07223437 Sponsor: University of Tennessee Graduate School of Medicine Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT07223437
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are 18 years of age or older
  • People who have been diagnosed with peripheral arterial disease and have stable leg pain when walking (symptoms that have not changed for at least 6 months)
  • People whose ankle-brachial index (a blood pressure measurement comparing the ankle and arm) falls between 0.4 and 0.9
  • People whose doctor has referred them to a heart or lung rehabilitation program
  • People who have previously had a procedure to restore blood flow to their legs, as long as their symptoms are stable and other criteria are met

Who may not be able to join:

  • People who have had a recent abnormal resting heart tracing (ECG), a heart attack within the past 2 weeks, or another recent acute heart event
  • People who have unstable chest pain (angina)
  • People who have heart rhythm problems that are not under control
  • People who have severe narrowing of the aortic heart valve with symptoms, or another significant heart valve condition
  • People whose heart failure is currently causing symptoms and is not well managed
  • People who have had a recent blood clot in the lungs
  • People who have an active non-heart-related illness that could be made worse by exercise, such as an infection or an overactive thyroid
  • People who currently have inflammation of the heart muscle or the sac surrounding the heart
  • People who have an inflamed vein with a blood clot (thrombophlebitis) that is currently active
  • People who have a physical disability that would make safe exercise impossible
  • People who have significantly abnormal levels of minerals or salts in the blood (such as potassium or sodium)
  • People who have a heart rhythm that is significantly too fast or too slow and is not being managed
  • People who have a significant blockage in the heart's electrical conduction system (high-degree heart block)
  • People who have an irregular heart rhythm (atrial fibrillation) with a heart rate that is not under control
  • People who have a thickened heart muscle condition (hypertrophic obstructive cardiomyopathy) with a resting blockage measurement of more than 25 mmHg
  • People who have a known, currently active tear in the main artery of the body (aortic dissection)
  • People whose resting blood pressure is severely elevated (top number above 200 or bottom number above 110)
  • People whose level of cognitive impairment would prevent them from following study instructions
  • People who are currently pregnant
  • People who have moderate to severe nerve damage in the hands or feet (peripheral neuropathy)
  • People who have open wounds or broken skin near where a blood flow restriction cuff would be placed
  • People who have an active deep vein blood clot, or who have had a serious blood clot event within the past year

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +1865-305-4682

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University of Tennessee Graduate School of Medicine
Registry
ClinicalTrials.gov
Start date
27 April 2026
Est. completion
27 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Walking Function; Quality of Life (QoL) (1); Quality of Life (QoL) (2); Quality of Life (QoL) (3)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov